Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Dicerna Pharmaceuticals, Inc.    DRNA

DICERNA PHARMACEUTICALS, INC.

(DRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

DICERNA PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)

10/22/2020 | 04:21pm EST
Item 8.01  Other Events.
On October 22, 2020, Dicerna Pharmaceuticals, Inc. issued a press release titled
"Dicerna Presents Positive New Interim Data From PHYOX™3 Long-Term, Open-Label
Extension Study of Nedosiran for Treatment of Primary Hyperoxaluria (PH)." A
copy of the press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.


Item 9.01  Financial Statements and Exhibits.
(d) Exhibits

Exhibit

     No.                                              Description
    99.1              Dicerna Presents Positive New Interim Data From 

PHYOX™3 Long-Term, Open-Label

                    Extension Study of Nedosiran for Treatment of Primary 

Hyperoxaluria (PH) .

     104            Cover Page Interactive Data File (embedded within the 

Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about DICERNA PHARMACEUTICALS, INC.
11/17DICERNA PHARMACEUTICALS : Announces FDA Acceptance of Lilly's Investigational Ne..
AQ
11/17DICERNA PHARMACEUTICALS : Announces Positive Updated Data from Phase 1 Trial of ..
AQ
11/16DICERNA PHARMACEUTICALS : Announces Positive Updated Data From Phase 1 Trial of ..
BU
11/16DICERNA PHARMACEUTICALS : Announces FDA Acceptance of Lilly's Investigational Ne..
BU
11/11DICERNA PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
BU
11/10DICERNA PHARMACEUTICALS : Presents New Nonclinical Research Highlighting the App..
BU
11/05DICERNA PHARMACEUTICALS : 3Q Earnings Snapshot
AQ
11/05DICERNA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
AQ
11/05DICERNA PHARMACEUTICALS : Announces Third Quarter 2020 Financial Results and Pro..
BU
11/05DICERNA PHARMACEUTICALS INC : Results of Operations and Financial Condition (for..
AQ
More news